{"transactions":[{"id":681558,"issuer":{"id":8408,"kind":"organization","name":"Calidi Biotherapeutics, Inc."},"owners":[{"id":21679,"kind":"person","name":"Jackson Andrew C.","position":1,"cik":"0001636738","reported_name":"Jackson Andrew C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (right to buy)","published_at":"2026-08-19T23:00:10.000Z","date":"2026-08-17","kind":"grant","planned":false,"acquired":true,"shares":14000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Issuer's 2023 Equity Incentive Plan (the \"2023 Plan\"), on August 17, 2026 (the \"Grant Date\"), the Reporting Person was granted 14,000 incentive stock options (the \"Options\") at an exercise price of $1.36, which is equal to the closing price of the Issuer's common stock on the Grant Date. 25% of the options will vest upon the one (1) year anniversary of 08/17/2026, and the remaining 75% of the options will vest in 1/36th installments on a monthly basis, subject to the Reporting Person's continued service to the Issuer. The Options were granted in a transaction exempt under Rule 16b-3 to the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include the incentive stock options previously granted to the Reporting Person."}],"balance_after":14000,"derivative":{"exercise_price":1.36,"exercise_date":"2026-08-17","expiration_date":"2036-08-17","underlying":"Common stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001493152-26-039289","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855485/000149315226039289/ownership.xml","form_type":"4"}},{"id":1046886,"issuer":{"id":8408,"kind":"organization","name":"Calidi Biotherapeutics, Inc."},"owners":[{"id":21679,"kind":"person","name":"Jackson Andrew C.","position":1,"cik":"0001636738","reported_name":"Jackson Andrew C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (right to buy)","published_at":"2025-09-05T23:56:26.000Z","date":"2025-09-03","kind":"grant","planned":false,"acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Issuer's 2023 Equity Incentive Plan (the \"2023 Plan\"), on September 3, 2025 (the \"Grant Date\"), the Reporting Person was granted 30,000 incentive stock options (the \"Options\") at an exercise price of $1.58, which is equal to the closing price of the Issuer's common stock on the Grant Date. 25% of the options will vest upon the one (1) year anniversary of 9/03/2025, and the remaining 75% of the options will vest in 1/36th installments on the last day of each monthly period subject to the Reporting Person's continued service to the Issuer. The Options were granted in a transaction exempt under Rule 16b-3 to the Reporting Person."}],"balance_after":30000,"derivative":{"exercise_price":1.58,"exercise_date":"2025-09-03","expiration_date":"2035-09-03","underlying":"Common stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001641172-25-026781","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855485/000164117225026781/ownership.xml","form_type":"4"}},{"id":1056883,"issuer":{"id":8408,"kind":"organization","name":"Calidi Biotherapeutics, Inc."},"owners":[{"id":21679,"kind":"person","name":"Jackson Andrew C.","position":1,"cik":"0001636738","reported_name":"Jackson Andrew C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Warrant (right to buy)","published_at":"2025-08-26T00:47:36.000Z","date":"2025-08-21","kind":"purchase","planned":false,"acquired":true,"shares":2500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The common stock and warrants were acquired by the reporting person in a public offering conducted by the Issuer that was closed on August 21, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each common share was purchased with an accompanying warrant for a purchase price of $2.00 per share and accompanying warrant."}],"balance_after":2500,"derivative":{"exercise_price":2,"exercise_date":"2025-08-21","expiration_date":"2030-08-21","underlying":"Common stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001641172-25-025445","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855485/000164117225025445/ownership.xml","form_type":"4"}},{"id":1056882,"issuer":{"id":8408,"kind":"organization","name":"Calidi Biotherapeutics, Inc."},"owners":[{"id":21679,"kind":"person","name":"Jackson Andrew C.","position":1,"cik":"0001636738","reported_name":"Jackson Andrew C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-26T00:47:36.000Z","date":"2025-08-21","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":2,"value":5000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The common stock and warrants were acquired by the reporting person in a public offering conducted by the Issuer that was closed on August 21, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each common share was purchased with an accompanying warrant for a purchase price of $2.00 per share and accompanying warrant."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001641172-25-025445","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855485/000164117225025445/ownership.xml","form_type":"4"}},{"id":1473364,"issuer":{"id":8408,"kind":"organization","name":"Calidi Biotherapeutics, Inc."},"owners":[{"id":21679,"kind":"person","name":"Jackson Andrew C.","position":1,"cik":"0001636738","reported_name":"Jackson Andrew C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (right to buy)","published_at":"2024-06-21T00:56:01.000Z","date":"2024-06-17","kind":"grant","planned":false,"acquired":true,"shares":300000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Issuer's 2023 Equity Incentive Plan (the \"2023 Plan\"), on June 17, 2024 (the \"Grant Date\"), the Reporting Person was granted 300,000 incentive stock options (the \"Options\") at an exercise price of $0.195, which is equal to the closing price of the Issuer's common stock on the Grant Date. 25% of the options will vest upon the one (1) year anniversary of 10/30/2023, and the remaining 75% of the options will vest in 1/36th installments on the last day of each monthly period subject to the Reporting Person's continued service to the Issuer. The Options were granted in a transaction exempt under Rule 16b-3 to the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Issuer's 2023 Equity Incentive Plan (the \"2023 Plan\"), on June 17, 2024 (the \"Grant Date\"), the Reporting Person was granted 300,000 incentive stock options (the \"Options\") at an exercise price of $0.195, which is equal to the closing price of the Issuer's common stock on the Grant Date. 25% of the options will vest upon the one (1) year anniversary of 10/30/2023, and the remaining 75% of the options will vest in 1/36th installments on the last day of each monthly period subject to the Reporting Person's continued service to the Issuer. The Options were granted in a transaction exempt under Rule 16b-3 to the Reporting Person."}],"balance_after":300000,"derivative":{"exercise_price":0.195,"expiration_date":"2034-06-17","underlying":"Common stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001493152-24-024599","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855485/000149315224024599/ownership.xml","form_type":"4"}},{"id":2243330,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":21679,"kind":"person","name":"Jackson Andrew C.","position":1,"cik":"0001636738","reported_name":"Jackson Andrew C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-06-06T21:01:15.000Z","date":"2022-06-03","kind":"grant","acquired":true,"shares":664800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable over four years (subject to continued service), with 25% of the shares vesting on May 31, 2023 and the remaining shares vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":664800,"derivative":{"exercise_price":0.6086,"expiration_date":"2032-06-03","underlying":"Common Stock, par value $0.005 per share","underlying_shares":664800},"source":{"system":"sec-edgar","filing":"0001140361-22-022025","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036122022025/form4.xml","form_type":"4"}},{"id":2258249,"issuer":{"id":8648,"kind":"organization","name":"Flyte Aviation, Inc."},"owners":[{"id":21679,"kind":"person","name":"Jackson Andrew C.","position":1,"cik":"0001636738","reported_name":"Jackson Andrew C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2022-05-24T20:33:57.000Z","date":"2022-05-20","kind":"tax_withholding","acquired":false,"shares":1361,"price":0.3013,"value":410.0693,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by the issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock awards. This is not an open market sale of securities."}],"balance_after":21680,"source":{"system":"sec-edgar","filing":"0001209191-22-031621","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636738/000120919122031621/doc4.xml","form_type":"4"}},{"id":2495286,"issuer":{"id":8648,"kind":"organization","name":"Flyte Aviation, Inc."},"owners":[{"id":21679,"kind":"person","name":"Jackson Andrew C.","position":1,"cik":"0001636738","reported_name":"Jackson Andrew C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2021-11-24T21:03:53.000Z","date":"2021-11-22","kind":"sale","acquired":false,"shares":2684,"price":2.62,"value":7032.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to satisfy the tax withholding requirement upon vesting of restricted stock awards."}],"balance_after":23041,"source":{"system":"sec-edgar","filing":"0001209191-21-066775","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1636738/000120919121066775/doc4.xml","form_type":"4"}},{"id":2495285,"issuer":{"id":8648,"kind":"organization","name":"Flyte Aviation, Inc."},"owners":[{"id":21679,"kind":"person","name":"Jackson Andrew C.","position":1,"cik":"0001636738","reported_name":"Jackson Andrew C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2021-11-24T21:03:53.000Z","date":"2021-11-20","kind":"disposition_to_issuer","acquired":false,"shares":11759,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents forfeiture of shares underlying restricted stock award granted on November 17, 2020."}],"balance_after":25725,"source":{"system":"sec-edgar","filing":"0001209191-21-066775","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636738/000120919121066775/doc4.xml","form_type":"4"}},{"id":2968155,"issuer":{"id":8648,"kind":"organization","name":"Flyte Aviation, Inc."},"owners":[{"id":21679,"kind":"person","name":"Jackson Andrew C.","position":1,"cik":"0001636738","reported_name":"Jackson Andrew C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2020-11-24T21:34:13.000Z","date":"2020-11-20","kind":"grant","acquired":true,"shares":200,"price":5.4315,"value":1086.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired through the issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":37484,"source":{"system":"sec-edgar","filing":"0001209191-20-060215","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636738/000120919120060215/doc4.xml","form_type":"4"}},{"id":2973168,"issuer":{"id":8648,"kind":"organization","name":"Flyte Aviation, Inc."},"owners":[{"id":21679,"kind":"person","name":"Jackson Andrew C.","position":1,"cik":"0001636738","reported_name":"Jackson Andrew C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2020-11-19T21:29:03.000Z","date":"2020-11-17","kind":"grant","acquired":true,"shares":35276,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were issued as a restricted stock award (\"RSA\"). 50% of the shares underlying the RSA shall vest and become non-forfeitable as follows:  1/3 of the number of shares will vest on November 20, 2021, and 1/6th of the number of shares will vest on each May 20 and November 20 thereafter, such that 50% of the RSA will be fully vested on November 20, 2023; provided, however, that if a vesting date would otherwise fall on a day when the national stock exchange upon which the shares are listed is not open for trading, vesting will occur on the first trading day thereafter. The remaining 50% of the shares underlying the RSA shall vest and become non-forfeitable upon certain performance milestones being met by November 20, 2021. Vesting in all instances is subject to the reporting person's continuous status as a Service Provider (as defined in the 2018 Equity Incentive Plan) through each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On November 16, 2020, the common stock of the company reverse-split 25-for-1, resulting in the reporting persons ownership being reduced by 48,194."}],"balance_after":37284,"source":{"system":"sec-edgar","filing":"0001209191-20-059388","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636738/000120919120059388/doc4.xml","form_type":"4"}},{"id":3067481,"issuer":{"id":8648,"kind":"organization","name":"Flyte Aviation, Inc."},"owners":[{"id":21679,"kind":"person","name":"Jackson Andrew C.","position":1,"cik":"0001636738","reported_name":"Jackson Andrew C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Warrants (right to buy)","published_at":"2020-08-05T21:10:52.000Z","date":"2020-08-03","kind":"purchase","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10000,"derivative":{"exercise_price":0.35,"exercise_date":"2020-08-03","expiration_date":"2025-08-04","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-20-045187","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1636738/000120919120045187/doc4.xml","form_type":"4"}},{"id":3067480,"issuer":{"id":8648,"kind":"organization","name":"Flyte Aviation, Inc."},"owners":[{"id":21679,"kind":"person","name":"Jackson Andrew C.","position":1,"cik":"0001636738","reported_name":"Jackson Andrew C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2020-08-05T21:10:52.000Z","date":"2020-08-03","kind":"purchase","acquired":true,"shares":10000,"price":0.35,"value":3500.0,"ownership":{"direct":true},"balance_after":50202,"source":{"system":"sec-edgar","filing":"0001209191-20-045187","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636738/000120919120045187/doc4.xml","form_type":"4"}},{"id":3133763,"issuer":{"id":8648,"kind":"organization","name":"Flyte Aviation, Inc."},"owners":[{"id":21679,"kind":"person","name":"Jackson Andrew C.","position":1,"cik":"0001636738","reported_name":"Jackson Andrew C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2020-05-27T21:05:59.000Z","date":"2020-05-22","kind":"purchase","acquired":true,"shares":10000,"price":0.4648,"value":4648.0,"ownership":{"direct":true},"balance_after":40202,"source":{"system":"sec-edgar","filing":"0001209191-20-032336","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636738/000120919120032336/doc4.xml","form_type":"4"}},{"id":3137254,"issuer":{"id":8648,"kind":"organization","name":"Flyte Aviation, Inc."},"owners":[{"id":21679,"kind":"person","name":"Jackson Andrew C.","position":1,"cik":"0001636738","reported_name":"Jackson Andrew C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2020-05-22T21:17:03.000Z","date":"2020-05-20","kind":"grant","acquired":true,"shares":5000,"price":0.4225,"value":2112.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired on May 20, 2020 through the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":30202,"source":{"system":"sec-edgar","filing":"0001209191-20-031833","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636738/000120919120031833/doc4.xml","form_type":"4"}},{"id":3331285,"issuer":{"id":8648,"kind":"organization","name":"Flyte Aviation, Inc."},"owners":[{"id":21679,"kind":"person","name":"Jackson Andrew C.","position":1,"cik":"0001636738","reported_name":"Jackson Andrew C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Interim CEO"}}],"security":"Common Stock","published_at":"2019-12-26T21:04:24.000Z","date":"2019-12-20","kind":"tax_withholding","acquired":false,"shares":4641,"price":0.901,"value":4181.541,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by the issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.  This is not an open market sale of securities."}],"balance_after":25202,"source":{"system":"sec-edgar","filing":"0001209191-19-061916","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636738/000120919119061916/doc4.xml","form_type":"4"}},{"id":3350871,"issuer":{"id":8648,"kind":"organization","name":"Flyte Aviation, Inc."},"owners":[{"id":21679,"kind":"person","name":"Jackson Andrew C.","position":1,"cik":"0001636738","reported_name":"Jackson Andrew C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Interim CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-05T23:20:03.000Z","date":"2019-12-03","kind":"grant","acquired":true,"shares":139052,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/12 of the total shares subject to the option shall vest every month after December 3, 2019, such that all shares subject to the option shall be fully vested on December 3, 2020, subject to the Reporting Person continuing to be a \"Service Provider\" (as defined in the Company's 2018 Equity Incentive Plan) through each vesting date."}],"balance_after":139052,"derivative":{"exercise_price":1.22,"expiration_date":"2029-12-03","underlying":"Common Stock","underlying_shares":139052},"source":{"system":"sec-edgar","filing":"0001209191-19-059368","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1636738/000120919119059368/doc4.xml","form_type":"4"}},{"id":3350870,"issuer":{"id":8648,"kind":"organization","name":"Flyte Aviation, Inc."},"owners":[{"id":21679,"kind":"person","name":"Jackson Andrew C.","position":1,"cik":"0001636738","reported_name":"Jackson Andrew C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Interim CEO"}}],"security":"Common Stock","published_at":"2019-12-05T23:20:03.000Z","date":"2019-12-04","kind":"tax_withholding","acquired":false,"shares":4505,"price":1.69,"value":7613.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by the issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.  This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Of the reported shares 13,424 shares are represented by Restricted Stock Units."}],"balance_after":29843,"source":{"system":"sec-edgar","filing":"0001209191-19-059368","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636738/000120919119059368/doc4.xml","form_type":"4"}},{"id":3487753,"issuer":{"id":8648,"kind":"organization","name":"Flyte Aviation, Inc."},"owners":[{"id":21679,"kind":"person","name":"Jackson Andrew C.","position":1,"cik":"0001636738","reported_name":"Jackson Andrew C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2019-06-17T21:23:06.000Z","date":"2019-06-13","kind":"sale","acquired":false,"shares":5134,"price":3.0763,"value":15793.7242,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Reporting Person's award agreement to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Of the reported shares 26,453 shares are represented by Restricted Stock Units."}],"balance_after":34348,"source":{"system":"sec-edgar","filing":"0001209191-19-037442","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636738/000120919119037442/doc4.xml","form_type":"4"}}]}